The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Nanoparticle-Based Vaccines Against Respiratory Viruses
Open accessAbstract
The respiratory mucosa is the primary portal of entry for numerous viruses such as the respiratory syncytial virus, the influenza virus and the parainfluenza virus. These pathogens initially infect the upper respiratory tract and then reach the lower respiratory tract, leading to diseases. Vaccination is an affordable way to control the pathogenicity of viruses and constitutes the strategy of choice to fight against infections, including those leading to pulmonary diseases. Conventional vaccines based on live-attenuated pathogens present a risk of reversion to pathogenic virulence while inactivated pathogen vaccines often lead to a weak immune response. Subunit vaccines were developed to overcome these issues. However, these vaccines may suffer from a limited immunogenicity and, in most cases, the protection induced is only partial. A new generation of vaccines based on nanoparticles has shown great potential to address most of the limitations of conventional and subunit vaccines. This is due to recent advances in chemical and biological engineering, which allow the design of nanoparticles with a precise control over the size, shape, functionality and surface properties, leading to enhanced antigen presentation and strong immunogenicity. This short review provides an overview of the advantages associated with the use of nanoparticles as vaccine delivery platforms to immunize against respiratory viruses and highlights relevant examples demonstrating their potential as safe, effective and affordable vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · cited 1×
“In fact, once internalized by APCs, these nanoparticles provide signals that trigger lysosomal destabilization and the production of reactive oxygen species (ROS), leading to the release of lysosomal contents, including the cysteine protease cathepsin B. This protease is sensed by NLRP3, which subsequently activates t…”
BackgroundThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2725 · Cited by 1,850
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
(1988) · World Health Organization eBooks · Cited by 1,574
Elwood, J. M. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.1.92 · Cited by 1,412
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 1×
“Subsequently, interleukins are produced as downstream signaling events, leading to the recruitment and/or activation of immune cells (35, (40) (41) (42) (43) (44) (45) .”
BackgroundPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
The Nalp3 inflammasome is essential for the development of silicosis
Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., & Sutterwala, F. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803933105 · Cited by 907
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Wang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Recent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts
Lawson, D. M., Artymiuk, P. J., Yewdall, S. J., Smith, J. M. A., Livingstone, J. C., Treffry, A., Luzzago, A., Levi, S., Arosio, P., Cesareni, G., et al. (1991) · Nature · doi:10.1038/349541a0 · Cited by 777 · cited 1×
“Other examples of SAPNs as potential nanovaccines against respiratory viruses include the capsid protein of the papaya mosaic virus (PapMV), the purified coronavirus spike protein and ferritin, which are selfassembling proteins that form rod-shaped and nearly spherical nanostructures, respectively (96, (130) (131) (13…”
BackgroundBruchard, M., Mignot, G., Derangère, V., Chalmin, F., Chevriaux, A., Végran, F., Boireau, W., Simon, B., Ryffel, B., Connat, J. L., et al. (2013) · Nature Medicine · doi:10.1038/nm.2999 · Cited by 774
Troeger, C., Forouzanfar, M., Rao, P. C., Khalil, I., Brown, A., Swartz, S., Fullman, N., Mosser, J., Thompson, R. L., Reiner, R. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30396-1 · Cited by 764
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Chitin and Chitosan: Structure, Properties and Applications in Biomedical Engineering
Islam, S., Bhuiyan, M. A. R., & Islam, M. N. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-016-0865-5 · Cited by 738
Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Green synthesis of nanoparticles: Their advantages and disadvantages
Parveen, K., Banse, V., & Ledwani, L. (2016) · AIP Conference Proceedings · doi:10.1063/1.4945168 · Cited by 654
Hiramatsu, H., & Osterloh, F. E. (2004) · Chemistry of Materials · doi:10.1021/cm049532v · Cited by 645
Transmission routes of respiratory viruses among humans
Kutter, J. S., Spronken, M. I., Fraaij, P. L., Fouchier, R. A., & Herfst, S. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.01.001 · Cited by 611 · cited 2×
“, droplets or aerosols), replicate efficiently in the respiratory tract and cause clinical manifestations, ranging from fever to bronchiolitis and pneumonia (3).”
BackgroundThe epidemiology of bovine respiratory disease: What is the evidence for predisposing factors?
Taylor, J. D., Fulton, R. W., Lehenbauer, T. W., Step, D. L., & Confer, A. W. (2010) · PubMed · Cited by 610
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
The Chemistry of the Sulfur–Gold Interface: In Search of a Unified Model
Pensa, E., Cortés, E., Corthey, G., Carro, P., Vericat, C., Fonticelli, M. H., Benítez, G., Rubert, A. A., & Salvarezza, R. C. (2012) · Accounts of Chemical Research · doi:10.1021/ar200260p · Cited by 558
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
Various methods of gold nanoparticles (GNPs) conjugation to antibodies
Jazayeri, M. H., Amani, H., Pourfatollah, A. A., Pazoki-Toroudi, H., & Sedighimoghaddam, B. (2016) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2016.04.002 · Cited by 528
Henrickson, K. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.242-264.2003 · Cited by 498
Construction and Characterization of Virus-Like Particles: A Review
Zeltins, A. (2013) · Molecular Biotechnology · doi:10.1007/s12033-012-9598-4 · Cited by 478
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Mazur, N. I., Higgins, D., Nunes, M. C., Melero, J. A., Langedijk, A. C., Horsley, N., Buchholz, U. J., Openshaw, P. J., McLellan, J. S., Englund, J. A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30292-5 · Cited by 457
Lynn, G. M., Laga, R., Darrah, P. A., Ishizuka, A. S., Balaci, A. J., Dulcey, A. E., Pechar, M., Pola, R., Gerner, M. Y., Yamamoto, A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3371 · Cited by 440
In vivo degeneration and the fate of inorganic nanoparticles
Feliu, N., Docter, D., Heine, M., del Pino, P., Ashraf, S., Kolosnjaj-Tabi, J., Macchiarini, P., Nielsen, P., Alloyeau, D., Gazeau, F., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00699f · Cited by 423
THE GENE STRUCTURE AND REPLICATION OF INFLUENZA VIRUS
Lamb, R. A., & Choppin, P. W. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.002343 · Cited by 393
Polymeric nanostructured materials for biomedical applications
Tang, Z., He, C., Tian, H., Ding, J., Hsiao, B. S., Chu, B., & Chen, X. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.05.005 · Cited by 363
Viral Infections of the Lower Respiratory Tract: Old Viruses, New Viruses, and the Role of Diagnosis
Pavia, A. T. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir043 · Cited by 354
Self-assembling protein nanoparticles in the design of vaccines
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.11.001 · Cited by 353
Recent Advances in Subunit Vaccine Carriers
Vartak, A., & Sucheck, S. (2016) · Vaccines · doi:10.3390/vaccines4020012 · Cited by 323
Economic Impact Associated with Respiratory Disease in Beef Cattle
Griffin, D. (1997) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/s0749-0720(15)30302-9 · Cited by 317
Inorganic nanoparticles for biomedicine: where materials scientists meet medical research
Giner-Casares, J. J., Henriksen-Lacey, M., Coronado-Puchau, M., & Liz-Marzán, L. M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.07.004 · Cited by 317
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313
Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 311
Biomaterials for Nanoparticle Vaccine Delivery Systems
Sahdev, P., Ochyl, L. J., & Moon, J. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1419-y · Cited by 310
Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M. H., Öörni, K., Wolff, H., Kovanen, P. T., Matikainen, S., & Eklund, K. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002843 · Cited by 298
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Coleman, C. M., Liu, Y. V., Mu, H., Taylor, J. K., Massare, M., Flyer, D. C., Glenn, G. M., Smith, G. E., & Frieman, M. B. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.016 · Cited by 293
Nanoparticles for nasal vaccination
Csaba, N., Garcia-Fuentes, M., & Alonso, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 277
Grohskopf, L. A., Sokolow, L. Z., Olsen, S. J., Bresee, J. S., Broder, K. R., & Karron, R. A. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6430a3 · Cited by 273
Carter, N. J., & Curran, M. P. (2011) · Drugs · doi:10.2165/11206860-000000000-00000 · Cited by 252
Silva, A. L., Soema, P. C., Slütter, B., Ossendorp, F., & Jiskoot, W. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1117714 · Cited by 251
Vaccines Through Centuries: Major Cornerstones of Global Health
Hajj Hussein, I., Chams, N., Chams, S., El Sayegh, S., Badran, R., Raad, M., Gerges-Geagea, A., Leone, A., & Jurjus, A. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00269 · Cited by 244
Harnessing nanoparticles for immune modulation
Getts, D. R., Shea, L. D., Miller, S. D., & King, N. J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.05.007 · Cited by 233
Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 233
Branche, A., & Falsey, A. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1584798 · Cited by 232
Vaccination and antigenic drift in influenza
Boni, M. F. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.011 · Cited by 226
Nanoparticles Mimicking Viral Surface Topography for Enhanced Cellular Delivery
Niu, Y., Yu, M., Hartono, S. B., Yang, J., Xu, H., Zhang, H., Zhang, J., Zou, J., Dexter, A., Gu, W., et al. (2013) · Advanced Materials · doi:10.1002/adma.201302737 · Cited by 207
Zuercher, A. W., Coffin, S. E., Thurnheer, M. C., Fundova, P., & Cebra, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1796 · Cited by 206
Mucosal Vaccine Design and Delivery
Woodrow, K. A., Bennett, K. M., & Lo, D. D. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150054 · Cited by 199
Zhao, Q., Li, S., Yu, H., Xia, N., & Modis, Y. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.002 · Cited by 197
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Deng, L., Mohan, T., Chang, T. Z., Gonzalez, G. X., Wang, Y., Kwon, Y.-M., Kang, S.-M., Compans, R. W., Champion, J. A., & Wang, B.-Z. (2018) · Nature Communications · doi:10.1038/s41467-017-02725-4 · Cited by 189
Pan, J., Wang, Y., Zhang, C., Wang, X., Wang, H., Wang, J., Yuan, Y., Wang, X., Zhang, X., Yu, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704408 · Cited by 174
Ferritin in the field of nanodevices
Yamashita, I., Iwahori, K., & Kumagai, S. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.005 · Cited by 172
Adaptations of nanoscale viruses and other protein cages for medical applications
LEE, L., & WANG, Q. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.07.009 · Cited by 168
Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
Kishimoto, T. K., & Maldonado, R. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00230 · Cited by 167
Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation
Chattopadhyay, S., Chen, J.-Y., Chen, H.-W., & Hu, C.-M. J. (2017) · Nanotheranostics · doi:10.7150/ntno.19796 · Cited by 166
Peptides conjugated to gold nanoparticles induce macrophage activation
Bastús, N. G., Sànchez‐Tilló, E., Pujals, S., Farrera, C., Kogan, M. J., Giralt, E., Celada, A., Lloberas, J., & Puntes, V. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.277 · Cited by 164
Nanoencapsulation for drug delivery
Kumari, A., Singla, R., Guliani, A., & Yadav, S. K. (2014) · EXCLI journal · doi:10.17877/de290r-15592 · Cited by 164
Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2
Utley, T. J., Ducharme, N. A., Varthakavi, V., Shepherd, B. E., Santangelo, P. J., Lindquist, M. E., Goldenring, J. R., & Crowe, J. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712144105 · Cited by 163
Applications of nanomaterials as vaccine adjuvants
Zhu, M., Wang, R., & Nie, G. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29589 · Cited by 160
Kang, S., Ahn, S., Lee, J., Kim, J. Y., Choi, M., Gujrati, V., Kim, H., Kim, J., Shin, E.-C., & Jon, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.024 · Cited by 159
Harnessing Nanoparticles for Immunomodulation and Vaccines
Gomes, A., Mohsen, M., & Bachmann, M. (2017) · Vaccines · doi:10.3390/vaccines5010006 · Cited by 158
Fromen, C. A., Robbins, G. R., Shen, T. W., Kai, M. P., Ting, J. P. ‐., & DeSimone, J. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422923112 · Cited by 147
Gold nanoparticle conjugates: recent advances toward clinical applications
Cao‐Milán, R., & Liz‐Marzán, L. M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.891582 · Cited by 143
Neto, L. M. M., Kipnis, A., & Junqueira‐Kipnis, A. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00239 · Cited by 138
Ulery, B. D., Kumar, D., Ramer‐Tait, A. E., Metzger, D. W., Wannemuehler, M. J., & Narasimhan, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017642 · Cited by 137
Harnessing self-assembled peptide nanoparticles in epitope vaccine design
Negahdaripour, M., Golkar, N., Hajighahramani, N., Kianpour, S., Nezafat, N., & Ghasemi, Y. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.05.002 · Cited by 136
Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy
Krasia‐Christoforou, T., & Georgiou, T. K. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20191k · Cited by 135
Kim, S., & Jang, Y. (2017) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2017.6.1.15 · Cited by 134
Dhakal, S., Hiremath, J. B., Bondra, K. M., Lakshmanappa, Y. S., Shyu, D.-L., Ouyang, K., Kang, K.-I., Binjawadagi, B., Goodman, J., Tabynov, K., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.039 · Cited by 125
Nanostructures for protein drug delivery
Pachioni-Vasconcelos, J. A., Lopes, A. M., Apolinário, A. C., Oses, J. K. V., Costa, J. S. R., Nascimento, L. D. O., Pessoa, A., Barbosa, L. R. S., & Rangel‐Yagui, C. D. O. (2015) · Biomaterials Science · doi:10.1039/c5bm00360a · Cited by 122
Spampinato, V., Parracino, M. A., Spina, R. L., Rossi, F., & Ceccone, G. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00008 · Cited by 122
Tao, W., Hurst, B. L., Shakya, A. K., Uddin, M. J., Ingrole, R. S. J., Sanabria, M. H., Arya, R. P., Bimler, L. H., Paust, S., Tarbet, E. B., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.01.021 · Cited by 122
Mamo, T., & Poland, G. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.023 · Cited by 116
Johnson, K. K., & Pendell, D. L. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00189 · Cited by 115
Polymer Chemistry Influences Monocytic Uptake of Polyanhydride Nanospheres
Ulery, B. D., Phanse, Y., Sinha, A. S., Wannemuehler, M. J., Narasimhan, B., & Bellaire, B. H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9760-7 · Cited by 114
Angioletti‐Uberti, S. (2017) · npj Computational Materials · doi:10.1038/s41524-017-0050-y · Cited by 111
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Sawaengsak, C., Mori, Y., Yamanishi, K., Mitrevej, A., & Sinchaipanid, N. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0058-7 · Cited by 105
Fredriksen, B. N., & Grip, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.105 · Cited by 103
Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses
Si, Y., Wen, Y., Kelly, S. H., Chong, A. S., & Collier, J. H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.031 · Cited by 103
Virus-sized vaccine delivery systems
Scheerlinck, J. Y., & Greenwood, D. L. V. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.016 · Cited by 99
Wang, C., Zhu, W. S., Luo, Y., & Wang, B. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.03.007 · Cited by 93
Kasturi, S. P., Kozlowski, P. A., Nakaya, H. I., Bürger, M. C., Russo, P., Pham, M., Kovalenkov, Y. O., Silveira, E. L. V., Havenar‐Daughton, C., Burton, S. L., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01844-16 · Cited by 92
Intranasal Delivery of Nanoparticle-Based Vaccines
Marasini, N., Skwarczyński, M., & Tóth, I. (2017) · Therapeutic Delivery · doi:10.4155/tde-2016-0068 · Cited by 90
Okamoto, S., Matsuura, M., Akagi, T., Akashi, M., Tanimoto, T., Ishikawa, T., Takahashi, M., Yamanishi, K., & Mori, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.037 · Cited by 89
Gold nanoparticles and vaccine development
Salazar-González, J. A., González‐Ortega, O., & Rosales‐Mendoza, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1064772 · Cited by 87
Materials design at the interface of nanoparticles and innate immunity
Szeto, G. L., & Lavik, E. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb01825k · Cited by 87
Live Attenuated Influenza Vaccine
Jin, H., & Subbarao, K. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_410 · Cited by 84
Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens
Carrillo‐Conde, B., Schiltz, E., Yu, J., Minion, F. C., Phillips, G. J., Wannemuehler, M. J., & Narasimhan, B. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.01.040 · Cited by 81
Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris
Scharf, B., Clement, C. C., Wu, X.-X., Morozova, K. S., Zanolini, D., Follenzi, A., Larocca, J. N., Levón, K., Sutterwala, F. S., Rand, J. H., et al. (2012) · Nature Communications · doi:10.1038/ncomms1754 · Cited by 80
Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers
Mora-Solano, C., Wen, Y., Han, H., Chen, J., Chong, A. S., Miller, M. L., Pompano, R. R., & Collier, J. H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.031 · Cited by 79
Wu, M., Zhao, H., Li, M., Yue, Y., Xiong, S., & Xu, W. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00445 · Cited by 75
McGill, J. L., Kelly, S. M., Kumar, P., Speckhart, S. L., Haughney, S. L., Henningson, J. N., Narasimhan, B., & Sacco, R. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21292-2 · Cited by 75
Liu, Q., Zheng, X., Zhang, C., Shao, X., Zhang, X., Zhang, Q., & Jiang, X. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24253 · Cited by 74
Amphiphilic Polyanhydride Nanoparticles Stabilize Bacillus anthracis Protective Antigen
Petersen, L. K., Phanse, Y., Ramer‐Tait, A. E., Wannemuehler, M. J., & Narasimhan, B. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2004059 · Cited by 72
Rahimian, S., Kleinovink, J. W., Fransen, M. F., Mezzanotte, L., Gold, H., Wisse, P., Overkleeft, H. S., Amidi, M., Jiskoot, W., Löwik, C. W. G. M., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.043 · Cited by 67
Wee, J. L. K., Scheerlinck, J. Y., Snibson, K. J., Edwards, S. J., Pearse, M. J., Quinn, C. T., & SUTTON, P. R. N. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.59 · Cited by 67
Rational Design of a Stable, Freeze-Dried Virus-Like Particle-Based Vaccine Formulation
Lang, R., Winter, G., Vogt, L., Zürcher, A., Dorigo, B., & Schimmele, B. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802192806 · Cited by 67
Promising approaches for the treatment and prevention of viral respiratory illnesses
Papadopoulos, N. G., Megremis, S., Kitsioulis, N. A., Vangelatou, O., West, P., & Xepapadaki, P. V. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.001 · Cited by 67
A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling
Thérien, A., Bédard, M., Carignan, D., Rioux, G., Gauthier-Landry, L., Laliberté-Gagné, M.-È., Bolduc, M., Savard, P. E., & Leclerc, D. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0289-y · Cited by 66
Ichinohe, T., Ainai, A., Tashiro, M., Sata, T., & Hasegawa, H. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.074 · Cited by 63
Preparation and in vitro immunomodulatory effect of curdlan sulfate
Li, P., Zhang, X., Cheng, Y., Li, J., Xiao, Y., Zhang, Q., Zong, A., Zhong, C., & Wang, F. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.10.078 · Cited by 60
Characteristics of Nasal-Associated Lymphoid Tissue (NALT) and Nasal Absorption Capacity in Chicken
Kang, H., Yan, M., Yu, Q., & Yang, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084097 · Cited by 60
Marasini, N., Giddam, A. K., Khalil, Z. G., Hussein, W. M., Capon, R. J., Batzloff, M. R., Good, M. F., Tóth, I., & Skwarczyński, M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0291 · Cited by 60
Hall, K., Zajdel, M. E. B., & Blair, G. E. (2010) · Biochemical Journal · doi:10.1042/bj20100766 · Cited by 58
Dabaghian, M., Latifi, A. M., Tebianian, M., Najminejad, H., & Ebrahimi, S. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.072 · Cited by 56
Hervé, P., Raliou, M., Bourdieu, C., Dubuquoy, C., Petit‐Camurdan, A., Bertho, N., Eléouët, J., Chevalier, C., & Riffault, S. (2013) · Journal of Virology · doi:10.1128/jvi.01141-13 · Cited by 55
Mansoor, F., Earley, B., Cassidy, J. P., Markey, B. K., Doherty, S., & Welsh, M. D. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0481-y · Cited by 54
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant
Francica, J. R., Lynn, G. M., Laga, R., Joyce, M. G., Ruckwardt, T. J., Morabito, K. M., Chen, M., Chaudhuri, R., Zhang, B., Sastry, M., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00370 · Cited by 53
PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania
Santos, D. M., Carneiro, M. W., de Moura, T. R., Soto, M., Luz, N. F., Prates, D. B., Irache, J. M., Brodskyn, C. I., Barral, A. M. P., Barral‐Netto, M., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.003 · Cited by 52
Safety and Biocompatibility of Carbohydrate-Functionalized Polyanhydride Nanoparticles
Vela-Ramirez, J. E., Goodman, J. T., Boggiatto, P. M., Roychoudhury, R., Pohl, N. L. B., Hostetter, J. M., Wannemuehler, M. J., & Narasimhan, B. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9699-z · Cited by 51
Etiology and Clinical Outcomes of Acute Respiratory Virus Infection in Hospitalized Adults
Seo, Y. B., Song, J. Y., Choi, M. J., Kim, I. S., Yang, T. U., Hong, K., Cheong, H. J., & Kim, W. J. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.2.67 · Cited by 50
Li, P., Tan, H., Xu, D., Yin, F., Cheng, Y., Zhang, X., Liu, Y., & Wang, F. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.04.025 · Cited by 49
Clinical characteristics of adenovirus associated lower respiratory tract infection in children
Lu, M., Ma, L., Zheng, Q., Dong, L., & Chen, Z. (2013) · World Journal of Pediatrics · doi:10.1007/s12519-013-0431-3 · Cited by 49
Walker, T. A., Khurana, S., & Tilden, S. J. (1994) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38876-9 · Cited by 49
Babin, C., Majeau, N., & Leclerc, D. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-10 · Cited by 48
Mathieu, C., Rioux, G., Dumas, M.-C., & Leclerc, D. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.02.009 · Cited by 46
Nanoparticle vaccines against respiratory viruses
Adair, B. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.45 · Cited by 44
Zilker, C., Kozlova, D., Sokolova, V., Yan, H., Epple, M., Überla, K., & Temchura, V. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.028 · Cited by 41
Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus
Babych, M., Bertheau-Mailhot, G., Zottig, X., Dion, J., Gauthier, L., Archambault, D., & Bourgault, S. (2018) · Nanoscale · doi:10.1039/c8nr05948a · Cited by 41
Self-citationMapletoft, J. W., Latimer, L. J. P., Babiuk, L. A., & den Hurk, S. V. D. L. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00250-09 · Cited by 35
Ding, P., Zhang, T., Li, Y., Teng, M., Sun, Y., Liu, X., Chai, S., Zhou, E., Jin, Q., & Zhang, G. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140789 · Cited by 35
Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic
Tai, W., Roberts, L., Seryshev, A. B., Gubatan, J. M. B., Bland, C., Zabriskie, R. C., Kulkarni, S., Soong, L., Mbawuike, I. N., Gilbert, B. E., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.50 · Cited by 34
Cai, M., Wang, C., Li, Y., Gu, H., Sun, S., Duan, Y., Lai, C., Wang, K., Yang, X., Xing, L., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw118 · Cited by 33
RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine
Hervé, P., Deloizy, C., Descamps, D., Rameix‐Welti, M., Fix, J., McLellan, J. S., Eléouët, J., & Riffault, S. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.006 · Cited by 31
Belmouaddine, H., Shi, M., Sanche, L., & Houde, D. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp02054j · Cited by 31
Ross, K. A., Haughney, S. L., Petersen, L. K., Boggiatto, P. M., Wannemuehler, M. J., & Narasimhan, B. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300525 · Cited by 27
McCormick, A. A., Shakeel, A., Yi, C., Kaur, H., Mansour, A. M., & Bakshi, C. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194614 · Cited by 16
The exciting potential of modular nanoparticles for rapid development of highly effective vaccines
Fogarty, J. A., & Swartz, J. R. (2017) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2017.11.001 · Cited by 11
Park, H., Lee, E., Jung, S.-Y., Ko, H. L., Lee, S., & Nam, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.198.supp.225.5 · Cited by 5
Cited by
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072657 · Cited by 686
Biological agents for synthesis of nanoparticles and their applications
Pandit, C., Roy, A., Ghotekar, S., Khusro, A., Islam, M. N., Emran, T. B., Lam, S. E., Khandaker, M. U., & Bradley, D. A. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.101869 · Cited by 446
Ahmad, F., Salem-Bekhit, M. M., Khan, F., Alshehri, S., Khan, A., Ghoneim, M. M., Wu, H.-F., Taha, E. I., & Elbagory, I. (2022) · Nanomaterials · doi:10.3390/nano12081333 · Cited by 356
Nanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Emerging Concepts and Technologies in Vaccine Development
Brisse, M., Vrba, S. M., Kirk, N., Liang, Y., & Ly, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583077 · Cited by 323
Metadata
- Authors
- Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S., & Archambault, D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-24
- Volume
- 10
- Pages
- 22-22
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2914729768
- Cited by
- 299
- References
- 144
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.